Company Information

EMMESSAR BIOTECH & NUTRITION LTD.

NSE : NABSE : 524768ISIN CODE : INE634B01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE38.68-0.29 (-0.74 %)
PREV CLOSE ( ) 38.97
OPEN PRICE ( ) 40.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5462
TODAY'S LOW / HIGH ( )38.00 40.00
52 WK LOW / HIGH ( ) 21.147.69
NSE
This Company is not listed in NSE
ChairmanSrinivasa Raghavan Mathurakavi Ayyangar
Managing DirectorSrinivasa Raghavan Mathurakavi Ayyangar
Company SecretaryPriyanka Sharma
Executive DirectorJeyavel B Nadar
Non Executive DirectorAnuradha Srinivasa Raghavan
Sarada Srinivasa Raghavan
Rajalakshmi Srinivasa Raghavan
Milind Sitaram Desai
Independent DirectorDinesh Kumar Deora
Non Executive Independent DirectorAnantharama Sethumani Subramanian
Incorporation Year : 1992

Registered Office :

Address : Plot No. T-3/2,M I D C Area,Raigad (Dist) Taloja,
Maharashtra-410208 .

Phone : 022-35661373 / 35664530

URL : www.ebnl.org

Industry : Pharmaceuticals & Drugs

Listing : BSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.